PureCycle Technologies, Inc. Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs
PureCycle Technologies, Inc. (PCT) had Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs of $0 as of 2023-12-31, per its 10-K filed 2024-03-06.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts · last filed 2024-03-06
- 2023-12-31: Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs $0.00.
- 2022-12-31: Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs $1.66M.
- 2021-12-31: Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs $2.69M.
- 2020-12-31: Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs $0.00.
| Period end | Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-06 |
| 2022-12-31 | $1.66M 10-K · filed 2024-03-06 |
| 2021-12-31 | $2.69M 10-K · filed 2023-03-16 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AdvanSix Inc. (ASIX) | United States | $0.426B | -30.25 |
| ROGERS CORP (ROG) | United States | $2.435B | -34.15 |
| AVIENT CORP (AVNT) | United States | $3.739B | 19.95 |
| HEXCEL CORP /DE/ (HXL) | United States | $6.464B | 49.18 |
| EASTMAN CHEMICAL CO (EMN) | United States | $7.575B | 17.34 |
| ALBEMARLE CORP (ALB) | United States | $12.778B | 71.05 |
| DuPont de Nemours, Inc. (DD) | United States | $17.580B | 1,010.90 |
| DOW INC. (DOW) | United States | $20.577B | -11.55 |